An evaluation of the change of plasma DHA concentration after the ingestion of DHA containing food.
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000035763
- Lead Sponsor
- Meiji CO.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Not provided
1)Subjects who routinely use pharmaceuticals, quasi-drugs and dietary supplement, and consume food for specified health uses more than two days per week 2) Subjects who have chronic diseases necessitating treatments and/or medications 3) Subjects who have significant abnormal blood pressure or blood test score 4) Subjects who have food allergy 5) Subjects who have lactose intolerance 6)Subjects who have digestive diseases or who received digestive surgical procedures 7) Subjects who are habitual smokers within a month of study enrollment 8) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month 9) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period 10)Subjects who determine ineligible by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma DHA concentration
- Secondary Outcome Measures
Name Time Method Plasma EPA concentration Plasma omega 3-fatty acids concentration(DHA and EPA) Plasma CCK concentration Plasma GLP-2 concentration